Navigation Links
Halozyme Therapeutics Presents Findings on Combinations of rHuPH20 Enzyme With Bisphosphonates at the American Association for Cancer Research Conference
Date:4/16/2008

President and Chief Scientific Officer. "We reasoned that if rHuPH20 hyaluronidase could rapidly disperse, dilute and systemically absorb bisphosphonates, it could prevent local irritation and facilitate conversion from intravenous infusion to a more convenient subcutaneous route of administration. These pre-clinical findings support this program's objective of developing what would be the only SC bisphosphonate on the market, in the event of continued success." The Company plans to bring its SC bisphosphonate program into the clinic in the third quarter of this year.

Bisphosphonates are a class of molecules that bind to mineralized bone matrix and inhibit bone resorption. Currently, there are oral and intravenous bisphosphonates. Oral Bisphosphonates often cause gastrointestinal side effects and require a cumbersome dosing regimen. The gastrointestinal side effects of oral bisphosphonates is a significant cause of patient non-compliance to prescribed therapy. Certain bisphosphonates are indicated for the treatment of osteoporosis and skeletal metastases, but can only be administered today by intravenous infusion. As such, patients often have to travel to an infusion center or see a specialist to receive their intravenous bisphosphonate infusion. Subcutaneous injections of bisphosphonates are not considered feasible due to injection site toxicity in the skin and/or impractical injection volumes.

The recombinant protein, rHuPH20, is a human hyaluronidase enzyme that increases the dispersion and systemic absorption of locally injected drugs by temporarily degrading hyaluronan under the skin.

About Halozyme Therapeutics, Inc.

Halozyme is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the drug delivery, oncology and dermatology markets. The company's portfolio of products and product candidates is based on intellectual property covering the family of human enzymes known as hyaluroni
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Halozyme Therapeutics Completes Enrollment in Chemophase Phase I/IIa Clinical Trial for Superficial Bladder Cancer
2. Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex
3. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
10. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
11. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013 Pharmacyclics, Inc. (the "Company") (Nasdaq: ... New England Journal of Medicine ( NEJM ) ... the investigational oral Bruton,s tyrosine kinase (BTK) inhibitor ibrutinib ... small lymphocytic lymphoma (SLL). Ibrutinib was shown to be ... SLL, even in patients who were at high-risk due ...
(Date:6/19/2013)... , June 19, 2013   NextDocs announced ... service clinical research organization, at DIA 2013 , ... companies will present case studies that explore best practices ... to electronic trial master file (eTMF) systems. ... will present alongside Krystyna Kowalczyk , executive vice ...
(Date:6/19/2013)... -- The Physician-Patient Alliance for Health & Safety recently released ... to urgently address this issue has been emphasized by ... "Medical device alarm safety in hospitals." According to The Joint ... 2012, there were 98 alarm related events reported, of which: ... 13 resulted in permanent loss of function (13%) , ...
Breaking Medicine Technology:Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 4Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 6NextDocs and Novella to Present on eTMF at DIA 2013 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3
(Date:6/19/2013)... 19, 2013 The benefits, NASS ... sauna but the overall experience for the majority of ... health-wise. , Mr Mouw, whose Virgina-based company enjoys an ... statement by saying that the type of sauna is ... number of counterfeit imitations which frankly, can be extremely ...
(Date:6/19/2013)... 2013 Across the globe billions of ... access to the medical advances that benefit developed western ... health care and the necessary aid to help curb ... , Outlook with Ben Kingsley is partnering ... in which these people live and highlight the invaluable ...
(Date:6/19/2013)... Denver, Colorado (PRWEB) June 19, 2013 Daily ... vertical jump training method will be published on ... a preview of the article to inform readers about the ... the declaration made by reporters working at Daily Gossip, the ... Manual Guide . , Hiller has understood during the ...
(Date:6/19/2013)... Are you using Twitter in your marketing campaigns? ... , Social media marketing is a proven and affordable ... Included in your social media campaigns should be Twitter messaging, ... and revenue for your business. , According to Statistic ... Many of these individuals are not just using the service ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Researchers from ... demonstrated several new studies at ENDO 2013, ... from June 15-18 in San Francisco.     , Mount Sinai ... as the role of prostastic acid phosphatase (PAP) in ... can stimulate the thyroid gland; revealed the prevalence of ...
Breaking Medicine News(10 mins):Health News:Health Benefits of Saunas Only Viable with Properly Constructed Models, Warns Manufacturer 2Health News:The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training 2Health News:If Your Massage Practice Isn’t Tweeting, It Isn’t Generating New Sales: 3 Ways Twitter Helps Grow Massage Practices from Appointment-Plus 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 3Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 4Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 5Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 6Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 7
... more stress can lead to the growth and spread of ... remarkable finding suggests that stress results in the release of ... released during stress stimulates cancer cells to produce two compounds ... the cells to move easily into the bloodstream and travel ...
... to treat seizures and migraine headaches, can increase the ... Southwestern Medical Center have found. ,A study – ... of topiramate affects kidney-stone formation – appears in the ... ,Several case reports have described an association ...
... from major depression can become symptom-free if they are ... treatments to determine which work best for them, which ... to the mix. ,The largest study on treatments ... that 67 percent of patients achieved a full remission ...
... bird flu virus has been detected in Asia, the British ... for any evidence of bird flu. ,The death ... and parks will be brought to the notice of the ... 1,200 sq Kms area will be brought under surveillance. ...
... world-wide survey which has sought to understand sexual behaviors ... pre-marital sex //in the present day are baseless and ... of this survey are published in The Lancet. ... which showed that many had just a single recent ...
... been grown from umbilical cord blood stem cells for the ... animal experiments for drug testing. ,According to the ... is just the initial phase of generating segments that can ... a mature functioning form. ,Scientists from Newcastle ...
Cached Medicine News:Health News:More Stress, More Cancer 2Health News:More Stress, More Cancer 3Health News:Drug Prescribed for Migraines and Seizures Increases Risk of Kidney Stones 2Health News:Drug Prescribed for Migraines and Seizures Increases Risk of Kidney Stones 3Health News:Carefully Monitored Treatment Can Help Those Who Suffer from Depression 2Health News:Carefully Monitored Treatment Can Help Those Who Suffer from Depression 3Health News:Artificial Liver from Cord Blood Stem cells 2
The Lineage acetabular system with ceramic liners uses sophisticated manufacturing methods and materials to minimize wear debris generation....
Hemisphere modular Cup....
Cer-Met series II system....
Derived from an extensive study into increasing the range of motion in hip replacement, the cemented SHP acetabular cup is a unique design and is manufactured from ArCom polyethylene....
Medicine Products: